Crestline Management’s Hologic HOLX Stock Holding History

Crestline Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,300	Closed	-$1.87M	–	242
2021 Q3	$1.87M	Buy	+25,300	New	+$1.9M	0.18%	108

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Crestline Management's HOLX Position: Q1 2025 in Review

Crestline Management sold out of Hologic (HOLX) in Q1 2025, closing a stake of 53,059 shares — an estimated $3.83M sold.

Crestline Management first reported a position in HOLX in Q3 2021 and held it in 4 quarters. The position peaked at $7.72M in Q4 2021. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

Crestline Management reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
Crestline Management sold 53,059 Hologic shares in Q1 2025, an estimated $3.83M.
Crestline Management first reported a position in Hologic in Q3 2021 and held it in 4 quarters.
Crestline Management's Hologic position peaked at $7.72M in Q4 2021.
706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.